Related Experiment Video
Updated: Mar 17, 2026

Intestinal Epithelial Regeneration in Response to Ionizing Irradiation
Published on: July 27, 2022
Chronic haemorrhagic radiation proctitis: A review
Vishnu Prasad Nelamangala Ramakrishnaiah1, Srinivasan Krishnamachari1
1Vishnu Prasad Nelamangala Ramakrishnaiah, Srinivasan Krishnamachari, Department of Surgery, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry 605006, India.
4% formalin is the recommended first-line treatment for chronic hemorrhagic radiation proctitis (CHRP). Argon plasma coagulation (APC) is equally effective, but formalin suits severe cases. Refractory patients may need hyperbaric oxygen or surgery.
Area of Science:
- Oncology
- Gastroenterology
- Radiation Medicine
Background:
- Chronic hemorrhagic radiation proctitis (CHRP) is a challenging complication post-pelvic radiation therapy.
- Standardized treatment protocols for CHRP are lacking, necessitating evidence-based reviews.
Purpose of the Study:
- To systematically review existing literature on CHRP treatments.
- To assess improvements in study methodologies and evidence quality compared to previous reviews.
Main Methods:
- A comprehensive literature search was conducted on PubMed/Medline and Google Scholar.
- Seventy studies, including 14 randomized controlled trials, focusing on rectal bleeding due to CHRP were selected.
Main Results:
- Methodologies of recent studies show improvement with objective assessments of symptoms, signs, and outcomes.
- Few studies have investigated the impact of CHRP treatments on patient quality of life.
Conclusions:
- 4% formalin is recommended as the first-line treatment for CHRP.
- Formalin and argon plasma coagulation (APC) demonstrate comparable efficacy, with formalin preferred for severe disease.
- Hyperbaric oxygen therapy or surgery are options for refractory cases; radio-frequency ablation requires further randomized trial investigation.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...

